z-logo
open-access-imgOpen Access
Self-Report Measures in the Assessment of Antiretroviral Medication Adherence
Author(s) -
Lassané Kaboré,
Paul Muntner,
Eric Chamot,
Anne Zinski,
Greer Burkholder,
Michael J. Mugavero
Publication year - 2014
Publication title -
journal of the international association of providers of aids care
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.813
H-Index - 31
eISSN - 2325-9582
pISSN - 2325-9574
DOI - 10.1177/2325957414557263
Subject(s) - medicine , confidence interval , viral load , visual analogue scale , antiretroviral therapy , medication adherence , gold standard (test) , pharmacy , human immunodeficiency virus (hiv) , antiretroviral medication , likert scale , physical therapy , family medicine , statistics , mathematics
Background: Adherence is a major determinant of the effectiveness of antiretroviral therapy (ART). We determined the association between self-reported adherence (SRA) and medication possession ratio (MPR), a pharmacy-based adherence measure, and their respective associations with viral load. Methods: Adherence to ART was assessed by MPR over 6 months and by self-report which included a question with a Likert-type scale response, a visual analogue scale (VAS), and an inquiry about the last time the patients skipped any prescribed medications. Results: Taking MPR as the “gold standard,” all 3 SRA measures displayed high specificity but low sensitivity. The prevalence ratio (95% confidence interval) for viral load ≥50 copies/mL was 2.19 (1.07-4.50) for MPR <90%, 1.98 (1.04-3.78) for poor/fair/good versus excellent/very good ability to take antiretroviral drugs, 1.47 (0.79-2.75) for skipping medications within the past 2 weeks, and 2.51 (1.39-4.53) for VAS <95%. Conclusion: These data suggest various SRA measures hold clinical value in screening for poor ART adherence.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here